Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 1/2006

01-01-2006 | Editorial Commentary

May we go on with antibacterial prophylaxis for urinary tract infections?

Author: R. Beetz

Published in: Pediatric Nephrology | Issue 1/2006

Login to get access

Abstract

Recurrent urinary tract infections (UTIs), with or without vesicoureteric reflux (VUR), are by far the most frequent reason for long-term antibacterial prophylaxis in infants and children today. However, the strategies of antibacterial prophylaxis for the prevention of recurrent urinary tract infection are no longer universally accepted. In infants and children at risk, the benefits of antibacterial prophylaxis definitively are not yet proven by evident data. To put antibacterial prophylaxis in its place, risk groups for recurrent symptomatic infections, ascending UTI and permanent renal damage have to be defined and the efficacy of prophylaxis in these groups has to be proved by prospective randomised studies. Nevertheless, until the results of these studies are available, antibacterial prophylaxis will remain one of the most frequently practised methods to protect risk patients from pyelonephritic damage and UTI recurrences.
Literature
1.
2.
3.
Marshall M Jr, Johnson SH (1956) An initial report of the treatment of chronic urinary tract infection in children with nitrofurantoin. J Urol 76:123–128PubMed
4.
Stansfield JM, Webb JGG (1954) A plea for the longer treatment of chronic pyelonephritis in children. BMJ 1:616–618CrossRef
5.
Smellie JM, Hodson CJ, Edwards D, Normand ICS (1964) Clinical and radiological features of urinary tract infection in childhood. Br Med J 2:1222–1226PubMedCentralPubMedCrossRef
6.
Smellie JM, Grüneberg RN, Leakey A, Atkin WS (1976) Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects. Br Med J 2:203–206PubMedCentralPubMedCrossRef
7.
Smellie JM, Katz G, Grueneberg RN (1978) Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet ii:175–178CrossRef
8.
Lohr JA, Nunley DH, Howards SS, Ford RF (1977) Prevention of recurrent urinary tract infections in girls. Pediatrics 59:562–565PubMed
9.
Smellie JM, Grüneberg RN, Normand ICS, Bantock HM (1982) Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection. Rev Infect Dis 4:461–466PubMedCrossRef
10.
Williams G, Lee A, Craig JC (2001) Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomised controlled trials. J Pediatr 138:868–874PubMedCrossRef
11.
Jodal U, Winberg J (1987) Management of children with unobstructed urinary tract infection. Pediatr Nephrol 1:647–656PubMedCrossRef
12.
Elder JS, Peters CA, Arant BS, Ewalt DH, Hawtrey CE, Hurwitz RS, Parrott TS, Snyder HM, Weis RA, Woolf SH, Hasselblad V (1997) Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157:1846–1851PubMedCrossRef
13.
Lindert KA, Shortliffe LMD (1999) Evaluation and management of pediatric urinary tract infections. Urol Clin North Am 26:719–728PubMedCrossRef
14.
15.
Fine RN (1992) Diagnosis and treatment of fetal urinary tract abnormalities. J Pediatr 121:333–341PubMedCrossRef
16.
Winberg J, Bollgren I, Källenius G, Möllby R, Svenson SB (1982) Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am 29:801–814PubMed
17.
Winberg J, Bergstrom T, Jacobsson B (1975) Mortality, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney Int [Suppl] S101–S106
18.
Nuutinen M, Uhari M (2001) Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol 16:69–72PubMedCrossRef
19.
McCracken GH (1984) Recurrent urinary tract infections in children. Pediatr Infect Dis 3:28–30CrossRef
20.
Kasanen A, Sundquist H, Elo J, Anttila M, Kangas L (1983) Secondary prevention of urinary tract infections. Ann Clin Res 15 [Suppl 36]: 5–36
21.
Kunin CM (1987) Detection, prevention and management of urinary tract infections. Lea & Febiger, Philadelphia
22.
Mannhardt W, Becker A, Putzer M, Bork M, Zepp F, Hacker J, Schulte-Wissermann H (1996) Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelial defense mechanism. Pediatr Nephrol 10:568–572PubMedCrossRef
23.
Hellerstein S, Nickell E (2002) Prophylactic antibiotics in children at risk for urinary tract infection. Pediatr Nephrol 17:506–510PubMedCrossRef
24.
Smellie JM, Grüneberg RN, Bantock HM, Prescod N (1988) Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children. Pediatr Nephrol 2:12–17PubMedCrossRef
25.
Jakobsson B, Nolstedt L, Svensson L, Söderlundh S, Berg U (1992) 99mTc-dimercaptosuccinic acid (DMSA) scan in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings. Pediatr Nephrol 6:328–334PubMedCrossRef
26.
Rushton HG, Majd M, Jantausch B, Wiedermann BL, Belman AB (1992) Renal scarring following reflux and nonreflux pyelonephritis in children: evaluation with 99mtechnetium-dimercaptosuccinic acid scintigraphy. J Urol 147:1327–1332PubMed
27.
Jodal U (1987) The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1:713–729PubMed
28.
Berg UB (1989) Renal dysfunction in recurrent urinary tract infections in childhood. Pediatr Nephrol 3:9–15PubMedCrossRef
29.
30.
Benador D, Benador N, Slozman D, Memillod B, Girardin E (1997) Are younger patients at higher risk of renal sequela after pyelonephritis? Lancet 349:17–19PubMedCrossRef
31.
Ransley PG, Risdon RA (1978) Reflux and renal scarring. Br J Radiol [Suppl] 14:1–35
32.
33.
Garin EH, Campos A, Homsy Y (1998) Primary vesicoureteral reflux: review of current concepts. Pediatr Nephrol 12:249–256PubMedCrossRef
34.
Wennerström M, Hansson S, Jodal U, Stokland E (2000) Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr 136:30–34CrossRef
35.
Rushton HG (1997) The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 11:108PubMedCrossRef
36.
Wheeler D, Vimalachandra D, Hodson EM, Roy KLP, Smith G, Craig JC (2003) Antibiotics and surgery for VUR: a meta-analysis of randomised controlled trials. Arch Dis Child 88:688–694PubMedCentralPubMedCrossRef
37.
38.
Le Saux N, Pham Ba’, Moher D (2000) Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ 163:523–529
39.
Jodal U (1994) Aspects of clinical trials of drug efficacy in children with uncomplicated infections. Infection 22: S10–S11PubMedCrossRef
40.
Reddy PP, Evans MT, Hughes PA, Dangman B, Cooper J, Lepow ML, Calvano CJ, Mandell J, (1997) Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance Pediatrics 100 [Suppl]:555
41.
Ransley PG, Dhillon HK, Gordon I, Duffy PG, Dillon MJ, Barratt TM (1990) The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol 144:584–587PubMed
42.
Madden NP, Thomas DF, Gordon AC, Arthur RJ, Irving HC, Smith SE (1993) Antenatally detected pelviureteric junction obstruction. Is non-operation safe? Br J Urol 68:305–310CrossRef
43.
Galloway A (1997) Prevention of urinary tract infection in patients with spinal cord injury—a microbiological review. Spinal Cord 35:198–204PubMedCrossRef
44.
Biering-Sorensen F, Hoiby N, Nordenbo A, Ravnborg M, Bruun B, Rahm V (1994) Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomised, cross-over, placebo-controlled study in patients with spinal cord lesion. J Urol 151:105–108PubMed
45.
Johnson HW, Anderson JD, Chambers GK, Arnold WJD, Irwin BJ, Brinton JR (1994) A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 93:752–755PubMed
46.
Kuhlemeier KV, Stover SL, Loyd LK (1985) Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 134:514–517PubMed
47.
Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 138:336–340PubMed
48.
Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, Vickrey BG (2002) Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 83:129–138PubMedCrossRef
49.
Nicolle LE (1992) Prophylaxis: recurrent urinary tract infection in women. Infection 20: S203–S205PubMedCrossRef
50.
Gupta K, Stamm WE (1999) Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 17:415–420PubMedCrossRef
51.
Nicolle LE, Ronald AR (1998) Recurrent urinary tract infection and its prevention. In: Brumfitt W, Hamilton-Miller JMT, Bailey RR (eds) Urinary tract infections. Chapman and Hall, Cambridge, UK, pp 293–301
52.
Stapleton A, Stamm WE (1997) Prevention of urinary tract infection. Infect Dis Clin North Am 11:719–734PubMedCrossRef
53.
Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE (1992) Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 [Suppl 1]:S216–S227
54.
Albert X, Huertas I, Pereiro I, Sanfelix J, Gosalbes V, Perrota C (2004) Antibiotics for preventing recurrent urinary tract infection in non-pregnant women (Cochrane Review). In: The Cochrane Library, Issue 3. Wiley, Chichester, UK
55.
Brumfitt W, Hamilton-Miller JMT (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 42:363–371PubMedCrossRef
56.
Miller T, Phillips S (1981) Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. Kidney Int 19:654–662PubMedCrossRef
57.
Winberg J (1994) Management of primary VUR in children—operation ineffective in preventing progressive renal damage. Infection 22 [Suppl 1]:4–7
58.
Hoberman A, Charran M, Hickey R, Baskin M, Kearney DH, Wald ER (2003) Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 348:251CrossRef
59.
Smellie J, Edwards D, Hunter N, Normand ICS, Prescod N (1975) VUR and renal scarring. Kidney Int 8:65–72CrossRef
60.
Merrick MV, Notghi A, Chalmers N, Wilkinson AG, Uttley WS (1995) Long-term follow-up to determine the prognostic value of imaging after urinary tract infections. Part 2: Scarring. Arch Dis Child 72:393–396PubMedCentralPubMedCrossRef
61.
Brendstrup L, Hjelt K, Petersen KE, Petersen S, Andersen EA, Daugbjerg PS, Stagegaard BR, Nielsen OH, Vejlsgaard R, Schou G (1990) Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. Acta Paediatr Scand 79:1225–1234PubMedCrossRef
62.
Holmberg L, Bowman G, Bottiger LE et al (1980) Adverse reactions to nitrofurantoin: analysis of 921 reports. Am J Med 69:733–738PubMedCrossRef
63.
Coraggio MJ, Gross TP, Roscelli JD (1989) Nitrofurantoin toxicity in children. Pediatr Infect Dis J 8:163–165PubMed
64.
Brumfitt W, Hamilton-Miller JMT (1995) A comparative trial of low-dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 23:99–102CrossRef
65.
Thompson RH, Chen JJ, Pugach J, Naseer S, Steinhardt GF (2001) Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol 168:1465CrossRef
66.
Coulthard MG (2002) Do kidneys outgrow the risk of reflux nephropathy? Pediatr Nephrol 17:477–480PubMedCrossRef
67.
Coulthard MG, Flecknell P, Orr H, Manas D, O’Donnell M (2002) Renal scarring caused by VUR and urinary infection: a study in pigs. Pediatr Nephrol 17:481–484PubMedCrossRef
68.
69.
Norrby SR (1992) Design of clinical trials in patients with urinary tract infections. Infection 20 [Suppl 3]: S181–S188
70.
Bollgren I (1999) Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl 431:48–52CrossRef
71.
Kaneko K, Ohtomo Y, Shimizu T, Yamashiro Y, Yamataka A, Miyano T (2003) Antibiotic prophylaxis by low-dose cefaclor in children with vesicoureteral reflux. Pediatr nephrol 18:468–470PubMed
72.
Daschner F, Marget W (1975) Treatment of recurrent urinary tract infection in children. II. Compliance of parents and children with antibiotic therapy regimes. Acta Paediatr Scand 64:105–108PubMedCrossRef
73.
Westenfelder M, Vahlensieck W, Reinartz U (1987) Patient compliance and efficacy of low-dose long-term prophylaxis in patients with recurrent urinary tract infection. Chemioterapia [Suppl 2]:530–532
74.
Montini G, Rigon L, Gobber D, Zuchetta P, Murer L et al on behalf of the IRIS (Italian Renal Infection Study) group (2004) A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis. Pediatr Nephrol 19:C71CrossRef
75.
Blumberg EA, Abruyn E (1997) Methods for the reduction of urinary tract infection. Curr Opin Urol 7:47–51CrossRef
76.
Mangiarotti P, Pizzini C, Fanos V (2000) Antibiotic prophylaxis in children with relapsing urinary tract infections: review. J Chemother 12:115–123PubMedCrossRef
Metadata
Title
May we go on with antibacterial prophylaxis for urinary tract infections?
Author
R. Beetz
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 1/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-2083-6

Other articles of this Issue 1/2006

Pediatric Nephrology 1/2006 Go to the issue

Book Review

C. Ronco, N.W. Levin (eds): Advances in end-stage renal diseases

Brief Report

Hemolytic uremic syndrome associated withEntamoeba histolytica intestinal infection

Letter to the Editors

IgA deficiency and membranous glomerulonephritis

Editorial Commentary

Steroid elimination is coming of age

Original Article

Tubular proteinuria in pre-term and full-term infants

Occasional Survey

Report of an NIH task force on research priorities in chronic kidney disease in children